Cell Therapies for Recurrent Implantation Failure (RIF) & Recurrent Miscarriage
Regenerative therapies are emerging treatments that aim to improve the uterine environment, enhance endometrial receptivity, promote healthy placental development, and support early pregnancy using the body's natural healing mechanisms. At Santasa Fertility, selected regenerative therapies are offered after a comprehensive evaluation of all possible causes.
Regenerative Pathways for RIF & Recurrent Loss
Enhance Receptivity
Optimizes endometrial environment for successful blastocyst implantation.
Placental Support
Promotes microvascular angiogenesis & spiral artery perfusion for early pregnancy.
Autologous PRP Instillation
Concentrated growth factors prepared from patient’s own blood with zero rejection risk.
Cell-Free Exosomes
Microscopic biological vesicles delivering microRNA repair signals to uterine tissue.
Understanding RIF & Recurrent Miscarriage
Recurrent Implantation Failure (RIF) refers to repeated failure of embryo implantation despite transferring good-quality embryos. Recurrent miscarriage is defined as two or more consecutive pregnancy losses. Detailed evaluation is essential before considering regenerative therapies.
Contributing Factors to RIF
Common Causes of Recurrent Miscarriage
Autologous PRP for RIF & Recurrent Miscarriage
Platelet-Rich Plasma (PRP) is prepared from the patient's own blood and contains high concentrations of natural growth factors. When administered into the uterine cavity prior to embryo transfer, PRP supports tissue regeneration and embryo-endometrial communication:
How PRP Helps RIF
Proposed Benefits for Recurrent Miscarriage
Endometrial Repair
Heals damaged lining layers for optimal gestational sac embedding.
Placental Development
Enhances vascularization at the early implantation site.
Anti-Inflammatory
Reduces local uterine inflammatory cytokines.
Early Support
Improves early pregnancy maintenance parameters.
Exosome Therapy & Immune Modulation
Exosomes are microscopic extracellular vesicles naturally released by cells. They carry proteins, growth factors, messenger RNA, and microRNA that regulate tissue repair, reduce inflammation, and promote cellular communication without using live cells.
Endometrial Receptivity
Promotes microvascular angiogenesis and optimal receptivity markers.
Immune Balance
Modulates maternal-fetal immune tolerance to protect early pregnancy.
Anti-Fibrotic Action
Reduces tissue scarring and chronic inflammatory responses.
Vessel Formation
Supports early placental vascular network development.
Clinical Care, ICMR Guidelines & FAQs
Regenerative Therapies Available at Santasa
Important ICMR / NMC Regulatory Advisory
Stem cell therapies for recurrent implantation failure and recurrent miscarriage remain investigational in India and are not permitted for routine clinical use outside approved research protocols. Santasa provides evidence-informed, non-stem cell PRP, PRF, and exosome therapies under strict ethical counseling and informed consent.
Overcome Implantation Failure & Recurrent Loss at Santasa
Schedule a detailed consultation with our senior reproductive medicine specialists to evaluate your case and discuss evidence-based regenerative options.